Search
Now showing items 1-7 of 7
Compositions and methods of enhancing immune responses to Eimeria
(United States. Patent and Trademark Office, 2015-02-17)
Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods ...
Compositions and methods of enhancing immune responses to Eimeria
(United States. Patent and Trademark Office, 2018-07-10)
Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods ...
Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection
(United States. Patent and Trademark Office, 2018-02-06)
Vaccine, vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection
(United States. Patent and Trademark Office, 2019-06-25)
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection
(United States. Patent and Trademark Office, 2020-10-06)
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
Compositions and methods of enhancing immune responses to Eimeria
(United States. Patent and Trademark Office, 2020-11-24)
Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods ...
Compositions And Methods Of Enhancing Immune Responses To Eimeria Or Limiting Eimeria Infection
(United States. Patent and Trademark Office, 6/21/2022)
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...